Incidence of Peri-Engraftment Acute Kidney Injury in Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide and Tacrolimus/Methotrexate-Based Graft-Versus-Host Disease Prophylaxis

被引：0

作者：

Myers, Mason J. ^{[1
]}

Palmer, Shannon ^{[1
]}

Coe-Eisenberg, Taylor ^{[1
]}

Cook, Rachel J. ^{[2
]}

Desai, Amrita ^{[3
]}

Meyers, Gabrielle ^{[3
]}

Saultz, Jennifer N. ^{[4
]}

Hayes-Lattin, Brandon ^{[3
]}

Newell, Laura F. ^{[3
]}

Leonard, Jessica T. ^{[3
]}

Maziarz, Richard T. ^{[3
]}

Gandhi, Arpita P. ^{[3
]}

机构：

[1] Oregon Hlth & Sci Univ, Pharm, Portland, OR USA

[2] Oregon Hlth & Sci Univ, Portland, OR USA

[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Ctr Hematol Malignancies, Portland, OR USA

[4] Oregon Hlth & Sci Univ, Div Hematol Med Oncol, Portland, OR USA

来源：

TRANSPLANTATION AND CELLULAR THERAPY | 2025年 / 31卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

800

引用

页码：S543 / S544

页数：2

共 50 条

[1] Post-transplant cyclophosphamide versus methotrexate-based regimen as graft-versus-host disease prophylaxis after allogeneic haematopoietic stem cell transplantation in patients with acute leukaemia
Elshamy, A. N.
Abdelmohsen, E. A.
Denewer, M. A.
Mabed, M. N.
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 5 - 6
[2] Post-Transplant Cyclophosphamide versus Methotrexate-Based Regimen as Graft Versus Host Disease Prophylaxis after Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Leukemia
El Shamy, Alaa
Elmohsen, Essam Abd
Denewer, Mai
Mabed, Mohamed
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S174 - S174
[3] Post-Transplant High Dose Cyclophosphamide and Bortezomib As Graft-Versus-Host Disease Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplantation
Bruno, Benedetto
Cirrone, Frank
Cole, Kelli
Stocker, Kelsey
Abdul-Hay, Maher
Suarez-Londono, J. Andres
Hochman, Tsivia
Goldberg, Judith
Al-Homsi, A. Samer Samer
BLOOD, 2021, 138
[4] Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
Lazzari, Lorenzo
Balaguer-Rosello, Aitana
Montoro, Juan
Greco, Raffaella
Hernani, Rafael
Lupo-Stanghellini, Maria Teresa
Villalba, Marta
Giglio, Fabio
Facal, Ana
Lorentino, Francesca
Guerreiro, Manuel
Bruno, Alessandro
Perez, Ariadna
Xue, Elisabetta
Clerici, Daniela
Piemontese, Simona
Luis Pinana, Jose
Angel Sanz, Miguel
Solano, Carlos
de la Rubia, Javier
Ciceri, Fabio
Peccatori, Jacopo
Sanz, Jaime
BONE MARROW TRANSPLANTATION, 2022, 57 (09) : 1389 - 1398
[5] Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia
Lorenzo Lazzari
Aitana Balaguer-Roselló
Juan Montoro
Raffaella Greco
Rafael Hernani
Maria Teresa Lupo-Stanghellini
Marta Villalba
Fabio Giglio
Ana Facal
Francesca Lorentino
Manuel Guerreiro
Alessandro Bruno
Ariadna Pérez
Elisabetta Xue
Daniela Clerici
Simona Piemontese
José Luis Piñana
Miguel Ángel Sanz
Carlos Solano
Javier de la Rubia
Fabio Ciceri
Jacopo Peccatori
Jaime Sanz
Bone Marrow Transplantation, 2022, 57 : 1389 - 1398
[6] Role of folinic acid in methotrexate-based prophylaxis of graft-versus-host disease following hematopoietic stem cell transplantation
AlJohani, Naif, I
HEMATOLOGY, 2021, 26 (01) : 620 - 627
[7] Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
Im, Annie
Rashidi, Armin
Wang, Tao
Hemmer, Michael
MacMillan, Margaret L.
Pidala, Joseph
Jagasia, Madan
Pavletic, Steven
Majhail, Navneet S.
Weisdorf, Daniel
Abdel-Azim, Hisham
Agrawal, Vaibhav
Al-Homsi, A. Samer
Aljurf, Mahmoud
Askar, Medhat
Auletta, Jeffery J.
Bashey, Asad
Beitinjaneh, Amer
Bhatt, Vijaya Raj
Byrne, Michael
Cahn, Jean-Yves
Cairo, Mitchell
Castillo, Paul
Cerny, Jan
Chhabra, Saurabh
Choe, Hannah
Ciurea, Stefan
Daly, Andrew
Diaz Perez, Miguel Angel
Farhadfar, Nosha
Gadalla, Shahinaz M.
Gale, Robert
Ganguly, Siddhartha
Gergis, Usama
Hanna, Rabi
Hematti, Peiman
Herzig, Roger
Hildebrandt, Gerhard C.
Lad, Deepesh P.
Lee, Catherine
Lehmann, Leslie
Lekakis, Lazaros
Kamble, Rammurti T.
Kharfan-Dabaja, Mohamed A.
Khandelwal, Pooja
Martino, Rodrigo
Murthy, Hemant S.
Nishihori, Taiga
O'Brien, Tracey A.
Olsson, Richard F.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (08) : 1459 - 1468
[8] Allogeneic Hematopoietic Stem Cell Transplantation After Solid Organ Transplantation in Patients With Hematologic Malignancies Managed With Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
Jang, Charley
Hsu, Jingmei
JOURNAL OF HEMATOLOGY, 2024, 13 (05) : 250 - 258
[9] Similar Cardiac Toxicity Following Allogeneic Hematopoietic Cell Transplant (alloHCT) with Post-Transplant Cyclophosphamide Versus Calcineurin Inhibitor-Based Graft-Versus-Host Disease Prophylaxis
Vazquez-Martinez, Mariola A.
Caprice, Teresa
Amisha, Fnu
Almaraz, Andrew
Kim, Jongphil
Cao, Biwei
Alomar, Mohammed E.
Khimani, Farhad
Mishra, Asmita
Nieder, Michael
Lazaryan, Aleksandr
Ochoa-Bayona, Jose L.
Nishihori, Taiga
Mirza, Sayeef
Faramand, Rawan
Perez, Lia
Anasetti, Claudio
Pidala, Joseph A.
Bejanyan, Nelli
Elmariah, Hany
BLOOD, 2024, 144 : 4871 - 4872
[10] Optimization of Tacrolimus Serum Levels When Combined with Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis after Hematopoietic Cell Transplantation: Outcome Data Analysis
Yao, Janny M.
Yang, Dongyun
Mokhtari, Saloomeh
Salhotra, Amandeep
Ali, Haris
Arslan, Shukaib
Otoukesh, Salman
Aldoss, Ibrahim
Sandhu, Karamjeet S.
Stein, Anthony
Snyder, David
Pullarkat, Vinod A.
Marcucci, Guido
Forman, Stephen J.
Nakamura, Ryotaro
Al Malki, Monzr M.
BLOOD, 2019, 134

← 1 2 3 4 5 →